Off-label use of GLP-1s among women of reproductive age has skyrocketed since 2020, with researchers concerned about its potential impact on unintended pregnancies Community pharmacists have an opportunity to counsel …

“Personal views” on adolescent sexual activity and contraceptive use should not interfere with the delivery of care, says expert Community pharmacies are often seen as an accessible setting for adolescents …

Novel working group of hospital pharmacists with a passion for medication guidelines finds success with <1% incident reports related to high-risk IV use A pharmacy team-based approach has consistently produced …

It opened its second “pharmacy health hub” utilising the service in Victoria Wesfarmers Health opened its second InstantScripts Pharmacy Health Hub in Amberly Park, Victoria, last week (28 August 2025). …

Nearly $7m in ineligible claims cancelled by Pharmacy Programs Administrator, and 46 providers suspended for “serious or repeated non-compliance” Close to 1,000 service providers have been investigated for non-compliance by …

Less than 15% of paediatric medicine labels met Australian standards on dosing instructions, new study finds The study, led by researchers from the University of Auckland’s School of Pharmacy, analysed …

Leading researchers have trialled a proactive model of care for pharmacists in general practice, but they warn of potential “roadblocks” to the role A promising trial shows the GP pharmacist …

The downscheduling of triptans in 2021 led to a drop in prescription-only dispensings, but the biggest savings are seen in general patients, say experts General patients with intermittent migraine were …

Industry first initiative helps pharmacy students during cost-of-living crisis, says NAPSA head LocumCo has extended its model to pharmacy students in an initiative it says creates new flexibility for pharmacies …

Blockbuster drug receives TGA approval for CKD indication, as wholesaler supply restrictions are lifted The TGA has approved glucagon-like peptide-1 receptor agonist (GLP1-RA) drug Ozempic (semaglutide 1.0mg) for a label …

Ignoring alerts on early supply, invalid repeats or mismatched patient details could risk triggering an audit, repayment, penalties or worse, warns Department of Health Government agencies, whistleblowers and sophisticated software …

Pharmacists share shocking case studies, with one seeing up to 1000-times dose errors for clonidine while another witnessed a child develop opioid dependency Leading pharmacists are warning the profession to …